From: PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer
CpG site | Normal control | Benign control | P |
---|---|---|---|
CpG 1 | Â | Â | 0.574 |
 Median (IQR) | 3 (2-4) | 1.5 (0-5.5) | |
CpG 2 | Â | Â | 0.728 |
 Median (IQR) | 2 (0-3) | 2.5 (0-8) | |
CpG 3 | Â | Â | 0.81 |
 Median (IQR) | 6 (2-12) | 10 (0-23) | |
CpG 4 | Â | Â | 0.137 |
 Median (IQR) | 3 (0-9) | 8 (3-14.5) | |
CpG 5 | Â | Â | 0.437 |
 Median (IQR) | 3 (0-6) | 4 (1-13.5) | |
CpG 6 | Â | Â | 0.11 |
 Median (IQR) | 3 (0-5) | 6 (1.5-16.5) | |
Average CpG | Â | Â | 0.65 |
 Median (IQR) | 4.83 (2.83-6.67) | 5.42 (2.67-12.67) |